Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Preferred Stock	Paid in capital	Accumulated deflicit	Accumulated other comprehensive loss
Beginning balance at Dec. 31, 2022	$ 10,452			$ 269,626	$ (259,154)	$ (20)
Beginning balance (in shares) at Dec. 31, 2022		2,175,936
Net Income (Loss)	(5,263)				(5,263)
Issuance of common stock	1,953			1,953
Issuance of common stock (in shares)		225,000
Issuance of preferred shares value	3,047			3,047
Issuance of preferred shares ( in shares)			351,037
Issuance of common stock upon exercise of stock options, RSUs and employee stock purchase plan	24			24
Issuance of common stock upon exercise of stock options, RSUs and employee stock purchase plan (in shares)		44,227
Vesting of restricted stock awards (in shares)		29,063
Share-based compensation expense related to issuance of stock options and RSUs to employees and employee stock purchase plan and restricted stock awards	1,042			1,042
Share-based compensation expense related to issuance of stock options to non-employees	25			25
Foreign currency translation adjustment	8					8
Fractional shares issuance		(67)
Ending balance at Dec. 31, 2023	11,288
Ending balance at Dec. 31, 2023	$ 11,288			275,717	(264,417)	(12)
Ending balance (in shares) at Dec. 31, 2023	2,474,159	2,474,159	351,037
Net Income (Loss)	$ (3,057)				(3,057)
Vesting of restricted stock awards (in shares)		71,763
Share-based compensation expense related to issuance of stock options and RSUs to employees and employee stock purchase plan and restricted stock awards	625			625
Foreign currency translation adjustment	(6)					(6)
Release of foreign currency translation adjustment upon liquidation of a subsidiary					(18)	$ 18
Ending balance at Dec. 31, 2024	8,850
Ending balance at Dec. 31, 2024	$ 8,850			$ 276,342	$ (267,492)
Ending balance (in shares) at Dec. 31, 2024	2,545,922	2,545,922	351,037